Guo and colleagues demonstrated that immunohistochemical staining for ECT2 on a human tissue microarray was positively associated with clinical pathological parameters such as Gleason score, pathological grade, clinical stage, tumor invasion, lymph node involvement, and distant PCa metastasis. Here, ECT2 is linked to neoplasm.